Publication | Open Access
BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer
26
Citations
40
References
2023
Year
These results reveal the immunosuppressive mechanism of tumorous BHLHE22 and provide a potential ICT combination therapy for patients with BHLHE22<sup>+</sup> PCa.
| Year | Citations | |
|---|---|---|
Page 1
Page 1